MP63-02 NEW OR WORSENING OVERACTIVE BLADDER SYMPTOMS AFTER RECOVERY FROM COVID-19

Abstract

You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction II (MP63)1 Sep 2021MP63-02 NEW OR WORSENING OVERACTIVE BLADDER SYMPTOMS AFTER RECOVERY FROM COVID-19 Wen Chen, Dragana Komnenov, Ryan Timar, Melissa Wills, Sorabh Dhar, and Nivedita Dhar Wen ChenWen Chen More articles by this author , Dragana KomnenovDragana Komnenov More articles by this author , Ryan TimarRyan Timar More articles by this author , Melissa WillsMelissa Wills More articles by this author , Sorabh DharSorabh Dhar More articles by this author , and Nivedita DharNivedita Dhar More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002103.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Since the emergence of the coronavirus disease (COVID-19) in December 2019, it has become evident that additional to the respiratory impairment, many other organ systems are targeted by the disease-causing SARS-CoV2 virus. Due to the paucity of data regarding genitourinary symptoms in COVID-19, we set out to investigate the disease manifestation(s) in bladder function. We identified recovered COVID-19 patients presenting with new or worsening overactive bladder symptoms, known as COVID-19 Associated Cystitis (CAC). METHODS: We used AUA Urology Care Foundation Overactive Bladder (OAB) Assessment Tool to screen COVID-19 recovered patients at our urban-located institution from 5/22/2020 to 12/31/2020. Primary outcomes include patient responses to 5 symptom and 4 quality-of-life questions (QOL). We reported median symptom scores, as well as quality-of-life scores, based on new or worsening urinary symptoms stratified by sex. RESULTS: We identified 350 patients with de novo or worsening OAB symptoms. In patients with new onset OAB symptoms, the median symptom score was 18. Patients with worsening OAB symptoms had a median pre-COVID-19 symptom score of 8 which was exacerbated post-COVID-19 as indicated by the median symptom score of 19. The median total QOL score for both men and women was 19. In patients with worsening OAB, median pre-COVID-19 QOL score was 9 compared to median post-COVID-19 QOL score of 20. Median age was 64.5 (range 47-82). Median length of stay was 10 days (range 5-30). CONCLUSIONS: Here we report survey-based results of patients suffering from new or worsening OAB symptoms after recovery from COVID-19 which necessitated hospitalization. The total median symptom score for patients with de novo OAB was 18 and QOL score was19, irrespective of sex, indicating moderate to severe OAB. Exacerbation of symptoms post-COVID-19 in patients with existing OAB was evident by increases in symptom severity scores and deteriorating QOL. At present, the pathophysiological mechanisms of de novo or worsening OAB symptoms after recovery from COVID-19 are unknown. Source of Funding: n/a © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1101-e1102 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Wen Chen More articles by this author Dragana Komnenov More articles by this author Ryan Timar More articles by this author Melissa Wills More articles by this author Sorabh Dhar More articles by this author Nivedita Dhar More articles by this author Expand All Advertisement PDF downloadLoading ...